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ABSTRACT  1	
Microglia, the resident macrophages of the central nervous system (CNS), are dynamic cells, 2	
constantly extending and retracting their processes as they contact and functionally regulate 3	
neurons and other glial cells. There is far less known about microglia-vascular interactions, 4	
particularly under healthy steady-state conditions. Here, we use the male and female mouse 5	
cerebral cortex to show that a higher percentage of microglia associate with the vasculature 6	
during the first week of postnatal development compared to older ages and the timing of these 7	
associations are dependent on the fractalkine receptor (CX3CR1). Similar developmental 8	
microglia-vascular associations were detected in the prenatal human brain. Using live imaging 9	
in mice, we found that juxtavascular microglia migrated when microglia are actively colonizing 10	
the cortex and became stationary by adulthood to occupy the same vascular space for nearly 2 11	
months. Further, juxtavascular microglia at all ages contact vascular areas void of astrocyte 12	
endfeet and the developmental shift in microglial migratory behavior along vessels 13	
corresponded to when astrocyte endfeet more fully ensheath vessels. Together, our data 14	
provide a comprehensive assessment of microglia-vascular interactions. They support a 15	
mechanism by which microglia use the vasculature to migrate within the developing brain 16	
parenchyma. This migration becomes restricted upon the arrival of astrocyte endfeet when 17	
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SIGNIFICANCE STATEMENT  27	
We report the first extensive analysis of juxtavascular microglia in the healthy, developing and 28	
adult brain. Live imaging revealed that juxtavascular microglia within the cortex are highly motile 29	
and migrate along vessels as they are colonizing cortical regions. Using confocal, expansion, 30	
super-resolution, and electron microscopy, we determined that microglia associate with the 31	
vasculature at all ages in areas lacking full coverage astrocyte endfoot coverage and motility of 32	
juxtavascular microglia ceases as astrocyte endfeet more fully ensheath the vasculature. Our 33	
data lay the fundamental groundwork to investigate microglia-astrocyte crosstalk and 34	
juxtavascular microglial function in the healthy and diseased brain. They further provide a 35	
potential vascular-dependent mechanism by which microglia colonize the brain to later regulate 36	
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INTRODUCTION  53	
While myeloid lineage in origin, microglia are now appreciated to be key cellular 54	
components of neural circuits. Imaging studies have revealed that microglia are constantly 55	
extending and retracting their processes, which are in frequent contact with neurons, synapses, 56	
and other glial cells (Davalos et al. 2005; Nimmerjahn, Kirchhoff, and Helmchen 2005; Schafer 57	
et al. 2012; Tremblay, Lowery, and Majewska 2010; Frost and Schafer 2016). These 58	
descriptions of physical interactions between microglia and other resident CNS cell types have 59	
now led to a new understanding that microglia are important for neural circuit structure and 60	
function, including their role in developmental synaptic pruning by engulfing and removing 61	
synapses from less active neurons (Schafer et al. 2012; Tremblay, Lowery, and Majewska 62	
2010; Paolicelli et al. 2011; Gunner et al. 2019). Besides interactions with parenchymal neurons 63	
and glia, microglia are known to interact with the vasculature. However, the vast majority of 64	
these studies have been in the context of disease where parenchymal microglia rapidly 65	
associate with the brain vasculature following breakdown of the blood-brain barrier (BBB) and, 66	
in turn, inflammatory microglia can modulate the breakdown of the BBB (Stankovic, Teodorczyk, 67	
and Ploen 2016; Zhao et al. 2018). Far less is known about how microglia interact with the 68	
vasculature in the healthy brain. With new evidence that microglia could be a conduit by which 69	
changes in peripheral immunity (e.g. microbiome, infection, etc.) affect CNS function 70	
(Hanamsagar and Bilbo 2017; Hammond, Robinton, and Stevens 2018; Zhao et al. 2018; 71	
Rothhammer et al. 2018) and mounting evidence that an array of neurological disorders have a 72	
vascular and microglial component (Daneman 2012; Hammond, Robinton, and Stevens 2018; 73	
Zhao et al. 2018), a greater understanding of microglia-vascular interactions is necessary. 74	
The neurovascular unit (NVU) is composed of endothelial cells, pericytes, vascular 75	
smooth muscle cells, astrocytes, macrophages, and neurons that connect the brain parenchyma 76	
to the cerebral vasculature. Interactions between these NVU cell types is important for a variety 77	
of physiological processes such as angiogenesis, vessel maintenance and permeability, 78	
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metabolic support, and regulation of blood flow (Brown et al. 2019; McConnell et al. 2017). The 79	
development of the NVU begins around embryonic day (E) 9.5 in mice, when specialized 80	
endothelial cells branch from vessels of the perineural vascular plexus to form capillaries that 81	
invade nearby neural tissue (Saili et al. 2017). Pericytes associate with endothelial cells as 82	
nascent vessels generate at E9.5 (Armulik et al. 2010; Bauer et al. 1993; Yamanishi et al. 2012; 83	
Daneman et al. 2010) and these interactions are critical to form the BBB (Zlokovic 2008; 84	
Daneman et al. 2010). Astrocytes are also a key component of the mature NVU. After the 85	
vasculature initially forms, astrocytes extend their processes to form endfeet over the course of 86	
postnatal development in rodents (Daneman et al. 2010). These astrocyte endfeet ultimately 87	
surround and ensheath the majority of the vasculature by adulthood where they play roles in a 88	
variety of functions such as maintaining the BBB, providing metabolic support to neurons, and 89	
regulating blood flow (Abbott, Rönnbäck, and Hansson 2006; Kimelberg and Nedergaard 2010; 90	
Macvicar and Newman 2015).  91	
The vast majority of studies assessing interactions between microglia and the 92	
vasculature are in the context of disease. For example, microglia rapidly surround and contact 93	
the vasculature following breakdown of the BBB in the inflamed CNS (Zhao et al. 2018; 94	
Stankovic, Teodorczyk, and Ploen 2016). One mechanism regulating these microglia-vascular 95	
interactions is the blood component fibrinogen and CD11b on microglia (Davalos et al. 2012; 96	
Adams et al. 2007). Reactive microglia can also influence the opening of the BBB by 97	
phagocytosing astrocyte endfeet or upregulating molecules such as VEGF, iNOS, and ROS 98	
(Stankovic, Teodorczyk, and Ploen 2016; Zhao et al. 2018; Haruwaka et al. 2019). In the 99	
healthy brain, much less is known. Studies in rodents and humans have shown that microglia 100	
associate with the vasculature in the developing CNS and live imaging in postnatal brain slices 101	
following traumatic injury or in embryonic mouse brain slices has suggested that microglia can 102	
migrate along the vasculature (Monier et al. 2007; Fantin et al. 2010; Smolders et al. 2017; 103	
Grossmann et al. 2002; Checchin et al. 2006). Microglia have also been suggested to regulate 104	
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vascular growth and complexity in the developing hindbrain and retina (Fantin et al. 2010; Rymo 105	
et al. 2011; Checchin et al. 2006; Yoshiaki Kubota et al. 2009; Dudiki et al. 2020). Together, 106	
these studies provide evidence that there is microglia-vascular crosstalk, which requires further 107	
investigation in development, adulthood, and disease.  108	
 In the current study, we investigated microglia-vascular interactions in the healthy, 109	
developing and adult cerebral cortex. Using confocal, super-resolution, expansion, and electron 110	
microscopy, we assessed the developmental regulation of physical associations between 111	
microglia and the vasculature and used fractalkine receptor (CX3CR1)-deficient mice to 112	
determine a role for this signaling in these physical associations. Using in vitro confocal and in 113	
vivo 2-photon live imaging, we further assessed the dynamics of juxtavascular microglia in real 114	
time. Our data support a mechanism by which microglia migrate along the vasculature to 115	
colonize the developing brain and the timing of these interactions is regulated by CX3CR1. This 116	
migratory behavior becomes restricted as astrocyte endfeet mature and suggests the 117	
establishment of a long-term niche for juxtavascular microglia in the adult brain.  118	
 119	
MATERIALS AND METHODS 120	
Animals 121	
Male and female mice were used for all experiments. Cx3cr1-/- mice (Cx3cr1EGFP/EGFP; stock 122	
#005582) and C57Bl6/J (stock #000664) mice were obtained from Jackson Laboratories (Bar 123	
Harbor, ME). Heterozygous breeder pairs were set up for all experiments and wild-type (WT) 124	
and heterozygote littermates were used as controls with equal representation of males and 125	
females for each genotype. All experiments were performed in accordance with animal care and 126	
use committees and under NIH guidelines for proper animal welfare. 127	
 128	
Human prenatal brain collection and immunofluorescence microscopy 129	
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Deidentified prenatal human brain tissues were collected via the Department of Pathology 130	
Autopsy Service at the University of California San Francisco under the approval of the 131	
Committee on Human Research (CHR, Study #: 12-08643). Brain tissues from four prenatal 132	
cases at 15, 18, 21 and 28 gestational weeks (GW) were evaluated using standard 133	
neuropathologic examinations to rule out any gross or microscopic abnormalities. These 134	
autopsy cases, which all had postmortem intervals of less than 48 hours, were fixed in freshly 135	
prepared 4% paraformaldehyde (PFA) and sampled at the level of the mammillary body. 136	
Following fixation in 4% PFA for 48 hours, brain samples were incubated with 20% sucrose 137	
solution, and were frozen in embedding medium OCT for cryosectioning at 20µm. For 138	
consistency, 3-6 consecutive sections were prepared from each sample and immunostained 139	
with anti-Iba1 antibody (Wako; Richmond, VA; 1:3000) and anti-CD31 antibody (R&D Systems; 140	
Minneapolis, MN; 1:200). Images of the ventricular and subventricular zones at the level of the 141	
frontal cortex were acquired on Leica SP8 confocal microscope using a 40X (1.3NA) objective 142	
lens. 143	
 144	
Preparation of tissue for immunofluorescence microscopy     145	
Mice were perfused with 1X Hank’s balanced salt solution (HBSS) -magnesium, -calcium, 146	
(Gibco, Gaithersburg, MD) prior to brain removal at indicated ages. For analysis of frontal and 147	
somatosensory cortex, brains were post-fixed in 4% paraformaldehyde in 0.1M phosphate 148	
buffer (PB) for four hours. Brains were placed in 30% sucrose in 0.1M PB and allowed to sink 149	
prior to sectioning. Sections were blocked in 10% goat serum, 0.01% TritonX-100 in 0.1M PB 150	
for 1 hour before primary immunostaining antibodies were applied overnight. Secondary 151	
antibodies were applied for two hours the following day. All steps were carried out at room 152	
temperature with agitation. For structured illumination microscopy (SIM), sections were blocked 153	
in 3% BSA, 0.01% TritonX-100 in 0.1M PB for 1 hour before primary immunostaining antibodies 154	
were applied for 48 hours at 4°C. Secondary antibodies were applied for four hours at room 155	
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temperature with agitation. The following antibodies were used: anti-P2RY12 (Butovsky 156	
Laboratory, Brigham and Women’s Hospital, Harvard University; 1:200), anti-PECAM 157	
(Biolegend; San Diego, CA; 1:100), anti-aquaporin 4 (Millipore Sigma; St. Louis, Missouri; 158	
1:200), anti-Pdgfrβ (Thermo Fisher Scientific; Waltham, MA; 1:200), anti-Lyve1 (Abcam; 159	
Cambridge, MA; 1:200), anti-smooth muscle actin (SMA) (Millipore Sigma; St. Louis, Missouri; 160	
1:200)  and anti-VGluT2 (Millipore Sigma; St. Louis, Missouri; 1:2000).  161	
 162	
Confocal microscopy  163	
Immunostained sections were imaged on a Zeiss Observer Spinning Disk Confocal microscope 164	
equipped with diode lasers (405nm, 488nm, 594nm, 647nm) and Zen acquisition software 165	
(Zeiss; Oberkochen, Germany). For microglia-vascular interaction, microglial density, microglia 166	
association with SMA+ or SMA- vessels and vascular density analyses, 20x, single optical 167	
plane, tiled images of the frontal or somatosensory cortex were acquired for each animal. To 168	
create a field of view (FOV), each tiled image was stitched using Zen acquisition software. Two 169	
FOVs (ie. tiled images) were acquired per animal. To note, anti-P2RY12 immunostaining was 170	
used to label microglia in wild type animals, which was more difficult to visualize at lower 171	
magnification at older ages compared to EGFP-labeled microglia. As a result, for anti-P2RY12 172	
immunostained sections from P7-P28 animals, twelve 40x fields of view were acquired per 173	
animal with 76 z-stack steps at 0.22µm spacing. For analysis of vascular diameter, 174	
juxtavascular association with branched/unsegmented vessels, primary processes aligned with 175	
vessels, astrocyte endfeet coverage on the vasculature, and vascular-associated microglia 176	
contacts with astrocytes, six-twelve 40X fields of view were acquired from the frontal cortex per 177	
animal with 76 z-stacks at 0.22µm spacing. 178	
 179	
Juxtavascular microglia and microglia density analyses in the frontal and somatosensory 180	
cortices  181	
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Using the DAPI channel as a guide, a region of interest (ROI) was chosen in each cortical layer, 182	
I-VI from each 20x stitched tiled image (10 ROIs per animal). Subsequent images were 183	
analyzed in ImageJ (NIH; Bethesda, MD). For anti-P2RY12, sections were acquired at 40x, a 184	
maximum intensity projection was made from each z-stack and was considered a ROI (12 per 185	
animal). The ROI areas were recorded. The same ROI was transposed on the microglial 186	
channel and the cell counter ImageJ plugin was used to count the number of microglia in the 187	
ROI. The total density of microglia was then calculated by dividing the microglia number by the 188	
ROI area. To assess microglial association with the vasculature, the microglia and blood vessel 189	
channels were merged and the cell counter plugin was used to manually count the number of 190	
microglia with cell bodies contacting blood vessels. Juxtavascular microglia were defined as 191	
microglia with at least 30% of their soma perimeter in contact with blood vessels and soma 192	
centers that were within 10µm of the vessel. The percent of juxtavascular microglia was 193	
calculated by summing the total number of microglia on vasculature divided by the total number 194	
of microglia within the ROI. For each animal, data from the ROIs were averaged together to get 195	
a single average per animal for statistical analyses.  196	
 197	
Juxtavascular microglia analysis within the barrel cortex 198	
Juxtavascular microglia analysis in the barrel cortex was performed blinded to genotype. 199	
Images were analyzed in ImageJ (NIH; Bethesda, MD). From each tiled image from each 200	
animal, 12-18 images containing VGluT2+ barrels were cropped for subsequent analyses. From 201	
each cropped image, the individual channels were separated and, using the free hand selection 202	
tool, each individual barrel was outlined. This ROI outlining the barrel was transposed to the 203	
microglia channel where the cell counter plugin was used to count the number of microglia in 204	
the barrels. The microglia and blood vessel channels were then merged and the same ROI was 205	
transposed onto the merged image. The cell counter plugin was used to count the number of 206	
microglia in barrels associated with vasculature. Each individual barrel ROI was then cleared, 207	
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leaving behind only the septa fluorescence and the cell counter plugin was again used to count 208	
the number of microglia and the number of juxtavascular microglia in the septa. To calculate the 209	
percent of juxtavascular microglia in the barrel cortex, the total numbers of juxtavascular 210	
microglia in the barrels and septa were summed and divided by the total number of microglia in 211	
the barrel and septa, respectively, for each ROI. The total microglia in barrels and septa, 212	
regardless of vascular association, were also calculated. All numbers across 12-18 cropped 213	
images were then averaged for a given animal prior to statistical analyses.  214	
 215	
Vascular density analysis 216	
Density analysis was performed blinded to genotype from the same tiled and stitched 20x 217	
images used for microglia-vascular association analyses. Using ImageJ (NIH; Bethesda, MD) 218	
software, the blood vessel channel was thresholded manually and the total blood vessel area 219	
was measured. Vascular density was calculated by dividing the blood vessel area by the area of 220	
the ROI. For each animal, the vascular density was averaged across all ROIs in the two FOV to 221	
get a single average per animal for statistical analyses.  222	
 223	
Microglial association with SMA+ or SMA- vessels analysis  224	
Using the DAPI channel as a guide, a region of interest (ROI) was chosen in each cortical layer, 225	
I-VI from each 20x stitched tiled image (10 ROIs per animal). Subsequent images were 226	
analyzed in ImageJ (NIH; Bethesda, MD). The same ROI was transposed on the microglial, 227	
Pdgfrβ, and SMA channel and the cell counter ImageJ plugin was used to count the total 228	
number of microglia, the number of juxtavascular microglia, and the number of juxtavascular 229	
microglia contacting SMA+ or SMA- vessels in the ROI. The percent of juxtavascular microglia 230	
contacting SMA+ or SMA- vessels was quantified by dividing the number of microglia on SMA+ 231	
or SMA- vessels by the number of total juxtavascular microglia. For each animal, data from the 232	
ROIs were averaged together to get a single average per animal for statistical analyses. 233	
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 234	
Vascular diameter analysis   235	
Using Imaris (Bitplane) software, the diameter of the vessel was measured in 3D at microglial 236	
soma contact points from 40X images (12 per animal). For each animal, data from the 12 237	
images were averaged together to get a single average per animal for statistical analysis. 238	
 239	
Primary Process and branched/unsegmented vessel analyses 240	
Using ImageJ (NIH; Bethesda, MD), the total number of primary processes, the number of 241	
primary processes aligned parallel with vessels, and whether the juxtavascular microglia was 242	
contacting a vessel branch point was calculated from 40X images (6 per animal, n=3-4 243	
animals). The percent of primary processes aligned with vessels was calculated by dividing the 244	
number of primary processes aligned parallel and in direct contact with vessels by the total 245	
number of primary processes. The percent of juxtavascular microglia contacting 246	
branched/unsegmented vessel was calculated by dividing the number of juxtavascular microglia 247	
contacting branched or unsegment vessels by the total number of juxtavascular microglia.  For 248	
each animal, data from 6 images were averaged together to get a single average per animal for 249	
statistical analysis.   250	
 251	
Acute Slice Time-Lapse Imaging 252	
Mice were given a retro-orbital injection of Texas Red labeled dextran (Fisher Scientific; 253	
Waltham, MA) 10 minutes prior to sacrifice to label vasculature. Mice were euthanized at P7 or 254	
P≥120, brains were isolated and sectioned coronally at a thickness of 300µm using a Leica 255	
VT1200 vibratome in oxygenated 37°C artificial cerebrospinal fluid (ACSF). Slices were 256	
mounted on a MatTak glass bottom microwell dish and placed in a Zeiss Observer Spinning 257	
Disk Confocal microscope equipped with diode lasers (405nm, 488nm, 594nm, 647nm) and Zen 258	
acquisition software (Zeiss; Oberkochen, Germany). Image acquisition started after a minimum 259	
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of 30 minutes of tissue equilibration at 37°C with 5% CO2 and within 2 hours of decapitation. 260	
Oxygenated ACSF was continuously perfused over the slices at a rate of 1.5-2µm/minute for the 261	
duration of equilibration and imaging. Per animal, one field of view was imaged every 5 minutes 262	
over 6 hours on an inverted Zeiss Observer Spinning Disk Confocal and a 20X objective. Z-263	
stacks spanning 50-60µm, with serial optical sections of 1.5-2µm were recorded from a minimal 264	
depth of 30µm beneath the surface of the slice to avoid cells activated by slicing. 265	
 266	
In vivo 2-Photon Time-Lapse Imaging 267	
Cranial window surgeries were performed as previously described within the visual cortex 268	
(2.5µm lateral and 2.0 µm posterior from bregma) (Goldey et al. 2014). One week after surgery, 269	
mice were head-fixed to a custom-built running wheel and trained to run while head restrained 270	
for increasing time intervals several days a week. Two weeks post surgery long-term 2-photon 271	
live imaging began.  Mice were given a retro-orbital injection of Texas Red labeled dextran 272	
(Fisher Scientific; Waltham, MA) 10 minutes prior to imaging and were head restrained on a 273	
custom built running wheel, which was positioned directly under the microscope objective. 274	
Images were acquired with a 20X water immersion objective (Zeiss, NA 1.0) on a Zeiss Laser 275	
Scanning 7 MP microscope equipped with a tunable coherent Chameleon Ultra II multiphoton 276	
laser and BiG detector. Three different regions of interest (ROIs) were taken at least 75µm 277	
below the surface of the brain, with z-stacks spanning 45-65µm with a step size of 2.5µm for 278	
each animal. On the first day of imaging, each ROI was imaged every 5 minutes over 2 hours. 279	
The same ROIs were then imaged once (single z-stack) on the following days post first imaging 280	
session: 1, 3, 7, 10, 14, 17, 21, 24, 28, 35, and 42 days. For each imaging day, the ROIs from 281	
day 0 of imaging were identified based on the vascular structure. 282	
 283	
Migration tracking and analysis 284	
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Image processing and microglial soma motility/migration tracking were performed using ImageJ 285	
(NIH; Bethesda, MD). Time series were first corrected for 3D drift using the 3D drift correction 286	
plugin (Parslow, Cardona, and Bryson-richardson 2014) and migration was tracked using the 287	
TrackMate plugin (Tinevez et al. 2017). For each developmental time point, 10-12 juxtavascular 288	
and vascular-unassociated microglia were analyzed per animal (n=4 mice per developmental 289	
time point). Only cells remaining in the field of view for six hours were included in the analysis. 290	
The average soma motility (µm/h) was calculated by measuring the displaced distance of the 291	
microglial soma between time=0 min and time=360 min and dividing by the duration of the 292	
imaging session. Juxtavascular distance migrated was calculated by measuring the displaced 293	
distance of the microglial soma between time=0 min and time=360 min. Juxtavascular migration 294	
trajectory was calculated by measuring the angle between the blood vessel and juxtavascular 295	
microglia soma along the longest, continuous stretch of motility on the vessel. Percent of cells 296	
within each binned category (motility, distance travelled, and trajectory) was calculated by 297	
dividing the number microglia of within each category by the total number of microglia. For each 298	
animal, data from each analyzed cell were averaged together to get a single average per animal 299	
for statistical analysis.  300	
 In vivo tracking of juxtavascular microglia motility and long-term juxtavascular microglia 301	
were performed using ImageJ (NIH; Bethesda, MD). Time series were first corrected for 3D drift 302	
using the 3D drift correction plugin (Parslow, Cardona, and Bryson-richardson 2014) and 303	
migration was tracked using the TrackMate plugin (Tinevez et al. 2017). To calculate percent of 304	
microglia stationary over two hours, the number of stationary juxtavascular and vascular-305	
unassociated microglia was divided by the total number of microglia.  To calculate the percent of 306	
original juxtavascular microglia that remain on vessels over 42 days, the number of 307	
juxtavascular microglia on day 0 was calculated. For each subsequent day, the number of these 308	
original juxtavascular microglia that were still associated with the vasculature was determined 309	
and divided by the number of original juxtavascular microglia on day 0. For each animal, data 310	
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was analyzed from three ROIs and averaged together to get a single average per animal for 311	
statistical analysis. For each animal, data was analyzed from three ROIs and added together to 312	
get a single average per animal for statistical analysis. 313	
 314	
Astrocyte endfeet coverage analysis  315	
Using Imaris (Bitplane) software, the astrocyte endfeet and vessel channels were 3D rendered 316	
from 40X images (6 per animal). The astrocyte channel was then masked onto the vessel 317	
channel and the masked astrocyte channel was 3D rendered. Volumes of the 3D rendered 318	
vessel channel and masked astrocyte endfeet channel were recorded. The percent of blood 319	
vessels covered by astrocyte endfeet was calculated by dividing the blood vessel volume by the 320	
masked astrocyte endfeet volume. For each animal, data from the 6 images were averaged 321	
together to get a single average per animal for statistical analysis. 322	
 323	
 Juxtavascular microglia- astrocyte contact  324	
Analysis was done using the same images used for astrocyte endfeet coverage analysis in 325	
Imaris (bitplane). The microglia was 3D rendered, masked onto the blood vessel and astrocyte 326	
endfeet channel, and the volume of the masked microglial channel was recorded. The percent 327	
of juxtavascular microglia contacting blood vessels only, vessels and astrocyte endfeet, or 328	
astrocyte endfeet only was calculated by summing the number of microglia contacting vessels 329	
only, vessels and astrocyte endfeet, or astrocyte endfeet only and dividing by the total number 330	
of juxtavascular microglia. For each animal, data from the 6 images were averaged together to 331	
get a single average per animal for statistical analysis. 332	
 333	
Expansion Microscopy (ExM) 334	
Expansion microscopy was performed as previously described (Asano et al. 2018) with slight 335	
modification. Briefly, 80µm floating sections were blocked in 0.5% bovine serum albumin (BSA) 336	
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and 0.3% Triton-X100 (TX-100) for 1 hour at room temperature.  Primary antibodies, anti-337	
aquaporin 4 (Millipore Sigma; St. Louis, Missouri; 1:200), anti-PDGFRβ (Thermo Fisher 338	
Scientific; Waltham, MA; 1:100), and anti-GFP (Abcam; Cambridge, MA; 1:200) were incubated 339	
in 0.5% BSA and 0.3% TX-100 at 4°C for 4 nights.  Secondary antibodies were added at 1:200 340	
dilutions overnight at room temperature.  Expansion microscopy protocol (Basic Protocol 2) was 341	
then followed as published in Asano et al. 2018. 342	
   343	
 Structured Illumination Microscopy (SIM) 344	
Structured Illumination Microscopy (SIM) was performed using a GE Delta Vision OMX V4 345	
microscope with pCO.edge sCMOS cameras and an Olympus 60x 1.42 NA objective. Samples 346	
were mounted in Prolong Glass mounting media with #1.5 coverslips and imaged using 1.516 347	
refractive index immersion oil. Image processing was completed using the GE softWorx 348	
software and image quality was determined using the SIMcheck plugin in ImageJ. SIM figures 349	
were produced in ImageJ (NIH; Bethesda, MD).  350	
 351	
Scanning Electron Microscopy (SEM)  352	
Mice were perfusion fixed in 2.5% glutaraldehyde and 2% paraformaldehyde in 0.1 M sodium 353	
cacodylate buffer at pH 7.4 (Science Services). Brains were dissected, vibratome sectioned, 354	
and immersion fixed for 24h at 4°C. We applied a rOTO (reduced osmium-thiocarbohydrazide-355	
somium) staining procedure adopted from Tapia et al. (Tapia et al. 2013). Briefly, the tissue was 356	
washed and post-fixed in 2% osmium tetroxide (EMS), 2% potassium hexacyanoferrate (Sigma) 357	
in 0.1 M sodium cacodylate buffer. After washes in buffer and water the staining was enhanced 358	
by reaction with 1% thiocarbohydrazide (Sigma) for 45 min at 50°C. The tissue was washed in 359	
water and incubated in 2% aqueous osmium tetroxide. All osmium incubation steps were carried 360	
out over 90 min with substitution by fresh reagents after 45 min, respectively. To further intensify 361	
the staining, 2% aqueous uranyl acetate was applied overnight at 4°C and subsequently 362	
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warmed to 50°C for 2h. The samples were dehydrated in an ascending ethanol series and 363	
infiltrated with LX112 (LADD). The samples were flat embedded into gelatin capsules (Science 364	
Services) and cured for 48h. The block was trimmed by 200 µm at a 90° angle on each side 365	
using a TRIM90 diamond knife (Diatome) on an ATUMtome (Powertome, RMC). Consecutive 366	
sections were taken using a 35° ultra-diamond knife (Diatome) at a nominal cutting thickness of 367	
100 nm and collected on freshly plasma-treated (custom-built, based on Pelco easiGlow, 368	
adopted from Mark Terasaki) CNT tape (Yoshiyuki Kubota et al. 2018). We collected 450 (P5) 369	
and 550 (P56) cortical sections, covering a thickness of 45-55 µm in depth. Tape strips were 370	
mounted with adhesive carbon tape (Science Services) onto 4-inch silicon wafers (Siegert 371	
Wafer) and grounded by additional adhesive carbon tape strips (Science Services). EM 372	
micrographs were acquired on a Crossbeam Gemini 340 SEM (Zeiss) with a four-quadrant 373	
backscatter detector at 8 kV. In ATLAS5 Array Tomography (Fibics), the whole wafer area was 374	
scanned at 3000 nm/pixel to generate an overview map. The entire ultrathin section areas of 375	
one wafer (314 sections (P5), 279 sections (P56)) were scanned at 100 x 100 x 100 nm3 (465 x 376	
638 µm2 (P5), 1249 x 707 µm2 (P56). After alignment in Fiji TrakEM2 (Cardona et al. 2012) 377	
areas that contained microglia in close proximity to blood vessels (148 x 136 x 16 µm3 (P5), 193 378	
x 186 x 12 µm3 (P56) were selected for high resolution acquisition. We collected 29 total 2D 379	
micrographs (10 x 10 nm2) from n=3 animals at P5 and 11 total micrographs from n=3 animals 380	
at P56. From each age, one juxtavascular microglia was identified and selected to generate a 381	
3D volume (10 x 10 x100 nm3). The image series were aligned in TrakEM2 using a series of 382	
automated and manual processing steps. For the P5 and P56 image series, segmentation and 383	
rendering was performed in VAST (Volume And Segmentation Tool) (Berger et al. 2018). We 384	
used Blender to render the two 3D models (Community 2018). 385	
 386	
Statistical analyses 387	
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GraphPad Prism 7 (La Jolla, CA) provided the platform for all statistical and graphical analyses. 388	
The ESD method was run for each ROI per animal to identify outliers. Significant outliers were 389	
removed prior to analyses. Analyses included Students t-test when comparing 2 conditions or 390	
one-way ANOVA followed by Dunnett’s post hoc analysis or two-way ANOVA followed by 391	
Sidak’s or Tukey’s post hoc analyses (indicated in figure legends).  392	
 393	
RESULTS 394	
A high percentage of microglia are juxtavascular during development  395	
During rodent and human embryonic development, microglia somas have been 396	
described to be in close contact with blood vessels (Fantin et al. 2010; Monier et al. 2007; 397	
Checchin et al. 2006). We assessed microglial association with the vasculature over an 398	
extended developmental time course across postnatal development. Microglia were labeled 399	
using transgenic mice that express EGFP under the control of the fractalkine receptor CX3CR1 400	
(Cx3cr1EGFP/+). The vasculature was labeled with an antibody against platelet endothelial cell 401	
adhesion molecule (PECAM). To start, we focused our analyses in the frontal cortex. 402	
Juxtavascular microglia were defined as microglia with at least 30% of their soma perimeter in 403	
contact with blood vessels and soma centers that were within 10µm of the vessel, which we 404	
confirmed with orthogonal views and 3D surface rendering (Fig 1. A-F; See also Movies 1 and 405	
2). Juxtavascular microglia were further distinguished from perivascular macrophages by their 406	
morphology with processes emanating from their soma and higher levels of EGFP. Using these 407	
criteria, we found a higher percent of the total microglial population were juxtavascular at P1-P5 408	
(Fig. 1G) in the frontal cortex, which was independent of sex (data not shown). The percent 409	
association dropped to below 20% by P14 and was maintained at later ages. We confirmed that 410	
this developmental regulation of juxtavascular microglia was independent of changes in 411	
vasculature density over development. While the total vascular content of the cortex increases 412	
as the brain grows, the density of the blood vessels within a given field of view is unchanged 413	
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across development (Fig. 1H). Consistent with the results in mouse, the ventricular and 414	
subventricular zones of the prenatal human brain at the level of the frontal cortex also showed a 415	
high percent of juxtavascular microglia. This association in the developing human brain peaked 416	
at 18-24 gestational weeks (GW) where 38% of total microglia were juxtavascular (Fig. 1I-J)—a 417	
percentage similar to what we identified in early postnatal mice. Together, these data 418	
demonstrate that a large percentage of the total microglia are juxtavascular in the early 419	
postnatal mouse and prenatal human brain.  420	
 421	
Juxtavascular microglia are largely associated with capillaries in the early postnatal 422	
cortex  423	
While previous work has described similar high association of microglia with the 424	
vasculature in the embryonic/prenatal brain, these studies did not use markers to distinguish 425	
microglia from perivascular macrophages (Fantin et al. 2010; Monier et al. 2007; Checchin et al. 426	
2006).  Therefore, we next sought to confirm that vascular-associated EGFP-positive cells were, 427	
indeed, microglia versus perivascular macrophages and determine which types of vessels were 428	
being contacted by microglia. We found that the juxtavascular EGFP+ cells that we initially 429	
identified as microglia based on their larger numbers of processes and higher levels of EGFP 430	
(Fig. 1; Fig. 2A-B filled arrowheads) were also positive for the microglia-specific marker P2RY12 431	
(Fig. 2A, filled arrowhead) and negative for the perivascular macrophage-specific marker LYVE1 432	
(Fig. 2B, unfilled arrowheads) (Butovsky et al. 2014; Zeisel et al. 2015). Using anti-P2RY12 to 433	
label microglia in wild-type mice or EGFP in Cx3cr1EGFP/+ mice, which are heterozygote for 434	
CX3CR1, we obtained similar percentages of juxtavascular microglial and vascular density (Fig. 435	
2C-D), confirming results were independent of the microglial labeling technique. We also found 436	
that these juxtavascular microglia were associated largely along unsegmented vessels, rather 437	
than branch points, across postnatal development (Fig. 2E). We next assessed what types of 438	
vessels were contacted by juxtavascular microglia, using a combination of parameters. 439	
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Capillaries are ≤8 µm in diameter and are smooth muscle actin (SMA)-negative and Platelet 440	
Derived Growth Factor Receptor β (PDGFRβ)-positive (Grant et al. 2019; Mastorakos and 441	
Mcgavern 2019). Arterioles are >8 µm in diameter and are SMA-positive and a subset of pre-442	
capillary arterioles are also PDGFRβ-positive (Grant et al. 2019). Using these markers, we 443	
identified that juxtavascular microglia were largely contacting capillaries (≤8 µm, SMA-negative, 444	
PDGFRβ-positive; Fig. 2F-H). These experiments establish that a large percentage of bona fide 445	
microglia are associated with unsegmented capillaries in the postnatal cerebral cortex and these 446	
percentages are similar in wild type and Cx3cr1EGFP/+ mice. 447	
 448	
High percentages of juxtavascular microglia occur when microglia are actively colonizing 449	
the cortex in a CX3CR1-dependent manner 450	
Over development, microglia undergo a dynamic process of colonization and expansion 451	
in a rostral-to-caudal gradient (Ashwell 1991; Perry, Hume, and Gordon 1985). Similar to 452	
previously published work (Nikodemova et al. 2015), we identified a large expansion in cortical 453	
microglia between P1 and P14, with microglia colonizing the more rostral frontal cortex region 454	
prior to the more caudal somatosensory cortex (Fig. 3A-C, bar graphs in B-C). Microglia-455	
vascular association mirrored this rostral-to-caudal gradient by which microglia colonize the 456	
brain with a higher percentage of juxtavascular microglia at P1-P5 (46.3% at P1 and 44.4% at 457	
P5) in the frontal cortex and at P5-P7 (39.1% at P5 and 34.2% at P7) in the more caudal 458	
somatosensory cortex (Fig. 3B-C, line graphs). Moreover, during times of active microglial 459	
colonization in both postnatal cortical regions (P1-P5 in the frontal cortex and P1-P7 in the 460	
somatosensory cortex), significantly more microglial primary processes were aligned parallel 461	
with vessels compared to older ages (Fig. 3D-G). This parallel juxtavascular microglial 462	
orientation along vessels is consistent with a migratory orientation.  463	
To further investigate microglia-vascular interactions in the context of colonization of the 464	
postnatal cortex, we assessed a somatosensory sub-region where the pattern of microglial 465	
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colonization has been well described—the barrel cortex. Layer IV of the barrel cortex contains 466	
thalamocortical synapses, which form a highly precise synaptic map of the vibrissae (whiskers) 467	
on the snout. These layer IV thalamocortical synapses form discrete barrel structures 468	
corresponding to each whisker, which are separated by septa where thalamocortical synapses 469	
are largely absent (Fig. 4A) (Woolsey and Van der Loos 1970; Welker and Woolsey 1974). 470	
Previous work has shown that microglia first localize to the septa and then colonize these 471	
thalamocortical synapse-dense barrel centers between P6 and P7 and this process is delayed 472	
to P8-P9 day in CX3CR1-deficient (Cx3cr1-/-) mice (Hoshiko et al. 2012). This delay in 473	
recruitment in Cx3cr1-/- mice is concomitant with a delay in synapse maturation. However, it was 474	
unclear how CX3CR1 was regulating the timing of microglial recruitment to synapses in the 475	
barrel cortex. To identify barrels, we labeled thalamocortical presynaptic terminals with an 476	
antibody against vesicular glutamate transporter 2 (VGluT2). Microglia were labeled with 477	
transgenic expression of EGFP in either Cx3cr1+/- (Cx3cr1EGFP/+) or Cx3cr1-/- (Cx3cr1EGFP/EGFP) 478	
mice. The vasculature was labeled with anti-PECAM. Similar to previous work (Hoshiko et al. 479	
2012), microglia infiltrated thalamocortical synapse-dense barrel centers (outlined with a yellow 480	
dotted line in Fig. 4C-F) from the septa by P6-P7 in Cx3cr1+/- mice and this process was 481	
delayed by one day in Cx3cr1-/- mice (Fig. 4B-D). Strikingly, just prior to entering barrel centers 482	
at P5-P6 in Cx3cr1+/- mice, a higher percentage of microglia were juxtavascular (Fig. 4E, G, 483	
arrowheads). Further, this microglia-vascular association was delayed by one day in Cx3cr1-/- 484	
mice (Fig. 4F-G), which is consistent with the delay in microglial migration into barrel centers in 485	
these mice (Fig. 4B). In both genotypes, the percentage of juxtavascular microglia decreased 486	
once the microglia began to colonize the thalamocortical synapse-dense barrel centers, P7 in 487	
Cx3cr1+/- mice and P8 in Cx3cr1-/- mice (Fig. 4F-G). These changes in microglia-vascular 488	
interactions were independent of any changes in total microglial or vascular density in layer IV 489	
(Fig. 4H-I), but rather specific to microglial distribution between the septa and barrels. These 490	
data are consistent with a model by which microglia use the vasculature to colonize synapse-491	
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dense cortical regions at the appropriate developmental timing. They further suggest that 492	
CX3CR1 signaling modulates the timing of microglial-vascular interactions and, subsequently, 493	
colonization to synapse-dense regions of the barrel cortex.  494	
 495	
Juxtavascular microglia migrate along the vasculature as they colonize the developing 496	
brain and are stationary in adulthood 497	
With data demonstrating that high percentages of microglia are juxtavascular when they 498	
are actively colonizing the brain with processes aligned parallel to the vessel, we next 499	
performed live imaging to assess migration. As the early postnatal cortex is challenging to 500	
image in vivo, we performed our initial analyses in acute cortical slices. Acute slices of 501	
somatosensory cortex were prepared from early postnatal (P7) and adult (P≥120) Cx3cr1EGFP/+ 502	
mice, which were given a retro-orbital injection of Texas Red labeled dextran to label blood 503	
vessels prior to slice preparation. We then imaged microglia every 5 minutes over 6 hours at 504	
both ages (Fig. 5A). Live imaging at P7 revealed significant juxtavascular microglial soma 505	
movement along blood vessels in the somatosensory cortex compared to vascular-506	
unassociated microglia at P7 (Fig. 5B, D, see also Movies 3-5). Specifically, 28.6% of 507	
juxtavascular microglia somas moved at a rate of 3-5µm/hour and another 26.1% moved at a 508	
rate of 5-7.5µm/hour (Fig. 5D).  In comparison, only 9.3% and 6.8% of vascular-unassociated 509	
microglia at the same age moved at 3-5µm/hour and 5-7.5µm/hour, respectively. We further 510	
found that when we assessed just the motile soma at P7, significantly more juxtavascular 511	
microglia somas travelled >20µm (30.9% traveled 20-30µm and 23.6% traveled 30-45µm) over 512	
6 hours  compared to vascular-unassociated microglia (7.5% and 6.8% traveled 20-30µm and 513	
30-45µm, respectively) (Fig. 5E). Importantly, the juxtavascular microglia soma velocities and 514	
distances traveled are consistent with the rate and distances at which microglia migrate to barrel 515	
centers within the somatosensory cortex in vivo where the distance between the septa and 516	
barrel center is ~80µm and it takes ~24 hours for microglia to reach the barrel center from the 517	
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septa. Demonstrating directional motility and suggesting migration along the vessel, 84.1% of 518	
these postnatal juxtavascular microglia had a motility trajectory of ≤15° along the blood vessel 519	
(Fig. 5F). Together, these data demonstrate directional migration of juxtavascular microglia at 520	
distances and speeds consistent with colonization of the cortex (P7).  521	
Interestingly, this migratory behavior along the vasculature was developmentally 522	
regulated and juxtavascular microglia in adult slices were largely stationary (Fig. 5C-D; see also 523	
Movie 6). We further confirmed the stationary phenotype of juxtavascular microglia in the adult 524	
cortex by in-vivo 2-photon live imaging in Cx3cr1EGFP/+ mice. Windows were placed over the 525	
visual cortex, which was most conducive to our head posts necessary for stabilizing the head in 526	
awake, behaving mice during imaging. We have found similar microglia-vascular interactions by 527	
static confocal imaging in the visual cortex (data not shown). Mice were given a retro-orbital 528	
injection of Texas Red labeled dextran to label blood vessels prior to imaging and juxtavascular 529	
microglia were imaged every 5 min over the course of 2 hours (Fig. 5G).  As observed in acute 530	
cortical slices, 100% of juxtavascular and vascular-unassociated microglia were stationary (Fig.  531	
5H; see also Movie 7). To further understand long-term dynamics, we imaged juxtavascular 532	
microglia in vivo over the course of 6 weeks (Fig. 5I). We identified that 82.9% of juxtavascular 533	
microglia present on day 0 of imaging remained on the vasculature 6 weeks later (Fig. 5J-K). 534	
Together, these data demonstrate that juxtavascular microglia in the postnatal cortex are highly 535	
migratory compared to non-vascular associated microglia. In contrast, juxtavascular microglia in 536	
adulthood are largely stationary, which suggests the establishment of a niche for juxtavascular 537	
microglia in the adult brain. 538	
 539	
Microglia associate with the vasculature in areas lacking full astrocyte endfoot coverage 540	
Our data demonstrate a strong microglial association and migration along the developing 541	
postnatal cortical vasculature. One possible mechanism regulating these developmental 542	
changes in juxtavascular microglia is the changing cellular composition of the NVU over 543	
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development. The neurovascular unit (NVU) begins to form during embryonic development, 544	
when pericytes associate with endothelial cells. Later in postnatal development, astrocytes are 545	
born and begin wrapping their endfeet around vessels until the vast majority of the vasculature 546	
is ensheathed by astrocyte endfeet by adulthood (Daneman et al. 2010; Schiweck, Eickholt, and 547	
Murk 2018; Bayraktar et al. 2015). As previously described (Daneman et al. 2010), the territory 548	
of Aquaporin 4 (AQP4)-positive astrocyte endfeet on PDGFRβ+ capillaries was low in the early 549	
postnatal cortex and then expanded over the first postnatal week (Fig. 6 A-D, bar graph in D). In 550	
more mature animals (≥P21), astrocytic endfeet covered ~85% of vessels in the frontal cortex. 551	
Intriguingly, this developmental timing of astrocyte endfoot coverage mirrored the 552	
developmental shift in the percentage of juxtavascular microglia in the cortex (Fig. 6D, line 553	
graph). That is, as the percentage of juxtavascular microglia decreased, astrocyte endfoot 554	
coverage increased. This astrocyte coverage also correlated with the timing of decreased 555	
microglial motility along the vessels (Fig. 5). We further assessed microglia-astrocyte endfoot 556	
interactions by confocal microscopy and 3D surface rendering. At all ages, microglia only 557	
contacted the vasculature in areas either completely void of astrocyte endfeet or in areas where 558	
vessels were not fully covered by the endfeet (Fig. 6 A-C, white arrow heads; Fig. 6E, see also 559	
Movies 8-10). Juxtavascular microglia were never in direct contact with solely astrocyte endfeet 560	
and no vessel at any age assessed (Fig. 6E). Given that cells of the NVU are nanometers apart 561	
from each other, we confirmed these results with expansion microscopy (ExM; Fig 6F-G), 562	
structured illumination microscopy (SIM; Fig. 6H-I) and electron microscopy (EM; Fig 7). By EM, 563	
microglia were identified based on characteristic microglial morphologies. Microglia nuclei tend 564	
to be half-mooned shape or long and thin with electron dense heterochromatin around the edge 565	
of the nucleus. Microglia were further distinguished by EM from perivascular macrophages by 566	
having processes emanating from the soma. Serial sectioning and 3D reconstruction of a 567	
representative cell captured by EM from each age confirmed that juxtavascular microglia 568	
contacted the basal lamina in vascular areas without full astrocyte endfoot coverage at all ages 569	
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(Fig. 7C, see also Movies 11 and 12). Together, these data demonstrate that juxtavascular 570	
microglia associate with the vascular basal lamina and associate with the vasculature in areas 571	
lacking full coverage by astrocyte endfeet. The data raise the intriguing possibility that lack of 572	
astrocyte endfeet in early postnatal development provides a permissive environment for 573	
juxtavascular microglial association with and migration along the vasculature as they colonize 574	
the brain.  575	
 576	
DISCUSSION  577	
 This study provides the first extensive analysis of juxtavascular microglia in the healthy 578	
developing and adult brain. We discovered that a high percentage of juxtavascular microglia are 579	
in direct contact with largely capillaries in the early postnatal mouse cortex. Similar microglia-580	
vascular association was observed in the developing human brain. Live imaging revealed that 581	
juxtavascular microglia are migratory along the vasculature during the peak of microglial 582	
colonization of the postnatal cortex and become stationary by adulthood. In addition, microglia 583	
are highly associated with the vasculature during development as they are being recruited to 584	
synapse-dense rich cortical regions and the timing of these interactions is regulated by 585	
CX3CR1. Last, we provide evidence that microglia preferentially contact the vasculature at all 586	
ages in areas lacking full astrocyte endfoot coverage and expansion of astrocytic endfeet along 587	
blood vessels coincides with a decrease in microglia migration along vessels. Taken together, 588	
these data suggest that microglia are using the vasculature to migrate and colonize the cortex 589	
and the timing of this vascular association is CX3CR1-dependent. Our data further support a 590	
mechanism in which microglial migration along the vasculature during development ceases and 591	
juxtavascular microglia become stationary upon the maturation of astrocyte endfeet. 592	
 593	
A possible role for the vasculature in regulating microglial colonization 594	
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 Microglia are born as primitive macrophages in the embryonic yolk sac and enter the 595	
neuroepithelium at embryonic day E9.5 by crossing the pial surface and lateral ventricles 596	
(Navascués et al. 2000; Swinnen et al. 2013; Ginhoux et al. 2010). Microglia then migrate and 597	
proliferate through the brain parenchyma in a rostral-to-caudal gradient to colonize the 598	
embryonic brain (Sorokin et al. 1992; Navascués et al. 2000; Swinnen et al. 2013; Alliot, Godin, 599	
and Pessac 1999; Perry, Hume, and Gordon 1985; Ashwell 1991). Signaling mechanisms have 600	
been identified to regulate initial microglial infiltration into the brain parenchyma, such as matrix 601	
metalloproteinases (MMPs), stromal cell derived factor 1 (SDF-1), and Cxcl12/Cxcr4 signaling 602	
(Ginhoux et al. 2010; Arno et al. 2014; Ueno and Yamashita 2014). However, far less is known 603	
about the mechanisms regulating microglial localization to the appropriate brain regions once 604	
they reach the parenchyma, particularly during postnatal development. Previous work has 605	
shown microglia can migrate along the vasculature in acute embryonic brain slices and brain 606	
slices prepared from postnatal mice in an injury context (Smolders et al. 2017; Grossmann et al. 607	
2002). In addition, other work has shown that oligodendrocyte precursor cells (OPCs) require 608	
the vasculature as a physical substrate for migration (Tsai et al. 2016). Similar findings have 609	
been identified for neural stem cells where the timing of astrocyte endfeet to the vessels has 610	
also been implicated (Bovetti et al. 2007; Fujioka, Kaneko, and Sawamoto 2019; Whitman et al. 611	
2009). We have identified that microglia are highly associated with vasculature during the peak 612	
of microglial colonization and recruitment to synapses. Furthermore, these vascular-associated 613	
microglia are migratory along blood vessels during early postnatal development and later 614	
become stationary once microglial colonization is complete. We also show in CX3CR1-deficient 615	
mice with known delays in microglial colonization of synapse-dense cortical regions that there 616	
are concomitant delays in microglial association with the vasculature. As we have observed no 617	
significant expression of Cx3cl1 (the CX3CR1 ligand) by vascular cells (Gunner et al. 2019) and 618	
a subset of microglia still associate with the vasculature in Cx3cr1-/- mice, this delay in microglial 619	
vascular association in Cx3cr1-/- mice is most likely due to disruptions in chemokine gradient 620	
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signaling from neuronal sources of CX3CL1 versus a direct effect of vascular adhesion. This 621	
would suggest that microglia receive directional cues from surrounding cells, use the 622	
vasculature as a physical substrate to migrate towards those cues, and the timing of this 623	
migration along the vasculature is regulated by CX3CR1. As Cx3cr1-/- mice have delays in 624	
synapse maturation and pruning and, long-term, have behavioral deficits consistent with an 625	
autism-like phenotype, it suggests that these microglia-vascular associations in development 626	
have long-term consequences (Paolicelli et al. 2011; Zhan et al. 2014; Hoshiko et al. 2012). The 627	
vascular cues regulating microglial adhesion and migration in the healthy CNS are yet to be 628	
identified, which will be key to determine the relative importance of microglia-vascular 629	
interactions for microglial colonization, brain development, and long-term CNS function. 630	
 631	
Microglia-astrocyte interactions at the NVU interface  632	
Another interesting direction is to determine the role of astrocyte endfeet in regulating 633	
microglia-vascular interactions. Astrocytes are born and begin wrapping their processes to form 634	
endfeet along blood vessels during the first postnatal week (Daneman et al. 2010). By 635	
adulthood, astrocytes endfeet ensheath 60-95% of the vasculature (Mathiisen et al. 2010; 636	
Korogod, Petersen, and Knott 2015). Here, we demonstrate that juxtavascular microglia in the 637	
postnatal cortex represent a large percentage of total microglia and are migratory along the 638	
vasculature. Juxtavascular microglia migration decreases as astrocyte endfeet develop and 639	
ensheath the vasculature. In addition, we showed that microglia contact vessels at all ages in 640	
areas lacking full astrocytic endfoot coverage and EM revealed high association between 641	
juxtavascular microglia and the vascular basal lamina. These data raise the intriguing possibility 642	
that the basal lamina provides an adhesive substrate for microglial association and migration, 643	
which becomes restricted upon astrocyte endfoot arrival. Astrocyte endfeet may, therefore, 644	
physically exclude microglia from contacting the basal lamina and associating with the 645	
vasculature. Another possibility is that microglia in the postnatal brain repel astrocyte endfeet, 646	
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but this repellent signal later decreases as the animal matures so that astrocyte endfeet can 647	
wrap the vessels. Analysis of astrocyte endfoot-juxtavascular microglia interactions along blood 648	
vessels will be important going forward.  649	
 650	
Possible functions for juxtavascular microglia in the healthy CNS 651	
Are juxtavascular microglia a unique subpopulation of microglial cells that perform 652	
distinct functions at the NVU? Evidence in the literature suggests microglia play important roles 653	
in regulating the vasculature, but it is unclear if these functions are specific to juxtavascular 654	
microglia. For example, in the embryonic brain, microglia are often localized to vascular junction 655	
points and depletion of all microglia is associated with a decrease in vascular complexity (Fantin 656	
et al. 2010). Similar findings have been identified in the developing retina (Rymo et al. 2011; 657	
Checchin et al. 2006; Dudiki et al. 2020). Our data demonstrating that microglia are localized to 658	
the vasculature prior to the arrival of the astrocyte endfeet could place microglia in a position to 659	
regulate fine-scale remodeling of the vasculature throughout the brain and/or help to maintain 660	
the BBB prior to astrocyte endfoot arrival. Arguing against the latter, microglia depletion during 661	
development does not appear to induce changes in BBB integrity in the postnatal brain 662	
(Parkhurst et al. 2013; Elmore et al. 2014). These data are in contrast to the inflamed adult 663	
CNS, were microglia regulate BBB integrity (Zhao et al. 2018; Stankovic, Teodorczyk, and 664	
Ploen 2016). One of the most recent studies shows that during systemic inflammation, 665	
parenchymal microglia migrate to the vasculature and help to maintain the BBB at acute stages 666	
(Haruwaka et al. 2019). However, with sustained inflammation, microglia phagocytose astrocyte 667	
endfeet and facilitate BBB breakdown. In the absence of inflammation, it remains unknown what 668	
functions juxtavascular microglia may perform. However, our in vivo live imaging data 669	
demonstrating microglia in the adult brain are stationary for nearly 2 months opens up the 670	
possibility that these cells reside in a vascular niche to perform specialized functions. One 671	
possible role could be to serve as immune surveillant “first responders”. We report that microglia 672	
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are in direct contact with the basal lamina at all ages in areas lacking astrocyte endfeet, which 673	
typically work to maintain the BBB (Abbott, Rönnbäck, and Hansson 2006; Kimelberg and 674	
Nedergaard 2010; Macvicar and Newman 2015). As a result, juxtavascular microglia in the 675	
healthy brain are in an ideal location to serve as conduits to relay changes in the peripheral 676	
environment (changes in the microbiome, infection, etc.) to the CNS. Indeed, many of these 677	
changes in peripheral immunity are known to directly impact neural circuit function and behavior 678	
in ways we do not yet fully understand (Hanamsagar and Bilbo 2017; Lebovitz et al. 2018; 679	
Abdel-haq et al. 2018) and recent work in the inflamed brain has demonstrated microglia can 680	
serve as a conduit by which the microbiome affects neuroinflammation (Rothhammer et al. 681	
2018).  682	
 683	
Microglia-vascular interactions: Implications for CNS disease 684	
Our findings have important implications for neurological diseases associated with the 685	
injured or aged CNS where there is enhanced microglial association with the vasculature, such 686	
as in stroke, brain tumors, multiple sclerosis (MS), and Alzheimer’s disease (Stankovic, 687	
Teodorczyk, and Ploen 2016; Zhao et al. 2018). This enhanced association can lead to further 688	
breakdown of the BBB and infiltration of peripheral immune cells into the CNS and possibly 689	
angiogenesis in the case of brain tumors (Stankovic, Teodorczyk, and Ploen 2016; Zhao et al. 690	
2018; Haruwaka et al. 2019). Therefore, understanding precisely when and where microglia 691	
interact with the vasculature in the healthy brain may lead to therapeutic strategies to reduce 692	
vascular pathology and facilitate recovery. One intriguing possibility is that these sites of 693	
microglial contact, which lack astrocyte endfeet, are more vulnerable to BBB breakdown and 694	
infiltration of peripheral immune cells and factors. In addition to neurodegenerative disorders, 695	
our findings may also have important implications for neurodevelopmental disorders such as 696	
autism spectrum disorders (ASDs). For example, microglia-vascular interactions may be 697	
important for the timing of microglial colonization to synapse-dense brain regions where they 698	
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regulate synapse maturation and pruning during critical windows in development (Paolicelli et al. 699	
2011; Hoshiko et al. 2012; Tremblay, Lowery, and Majewska 2010; Schafer et al. 2012; Gunner 700	
et al. 2019). If these interactions are disrupted, the timing of synapse development and, 701	
ultimately, neural circuit function may be altered. This is supported by our data from Cx3cr1-/- 702	
mice showing delays in microglial association with the vessels, which is concomitant with known 703	
delays in microglial recruitment to developing synapses and delays in synapse maturation in 704	
these mice (Paolicelli et al. 2011; Zhan et al. 2014; Hoshiko et al. 2012). Long term, Cx3cr1-/- 705	
mice have phenotypes associated with ASD, including decreased functional brain connectivity, 706	
deficits in social interactions, and increased repetitive behaviors (Zhan et al. 2014). However, a 707	
better understanding of how vascular interactions affect microglial colonization and extending 708	
these analyses of microglia-vascular interactions into the ASD human brain will be necessary.  709	
Together, our work sheds new light on an understudied population of microglia, 710	
juxtavascular microglia. This work lays the foundation for identifying new molecular mechanisms 711	
underlying microglia-vascular interactions, identifying mechanistic underpinnings of microglia-712	
astrocyte crosstalk at the level of the NVU, and furthering our understanding of juxtavascular 713	
microglia function in CNS homeostasis. With the vascular interface emerging as an important 714	
aspect of many neurological conditions, this study also lays the critical groundwork to study how 715	
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FIGURE LEGENDS 959	
Figure 1: A high percentage of microglia are juxtavascular during early postnatal 960	
development. A-B. Representative low magnification tiled images of microglia (green, EGFP) 961	
associated with vasculature (magenta, anti-PECAM) in the P5 (A) and P28 (B) frontal cortex. 962	
Filled arrowheads denote juxtavascular microglia. Scale bars= 100 µm (A) and 50 µm (B). C-D. 963	
High magnification, orthogonal view (C) and 3D reconstruction and surface rendering (D) of 964	
juxtavascular microglia in the P5 frontal cortex (see also Movie 1). Scale bars= 10 µm. E-F. 965	
Orthogonal (E) and 3D reconstruction and surface rendering (F) of a juxtavascular microglia in 966	
the P28 frontal cortex (see also Movie 2). Scale bars= 10 µm. G. The percent of the total 967	
microglia population associated with vasculature over development in the frontal cortex. One-968	
way ANOVA with Dunnett’s post hoc; comparison to P≥21, n=4 littermates per developmental 969	
time point, ****p<.0001. H. Vascular density over development in the frontal cortex. One-way 970	
ANOVA with Dunnett’s post hoc; comparison to P≥21, n=4 littermates per developmental time 971	
point. I. Representative image of microglia (green, anti-IBA1) associated with vasculature 972	
(magenta, anti-CD31) in gestational week (GW) 24 in the ventricular zone (VZ) and 973	
subventricular zone (SVZ) at the level of the human frontal cortex. Filled arrowheads denote 974	
juxtavascular microglia. Scale bar=20 µm. J. Quantification of the percentage of total microglia 975	
associated with vasculature in the human brain. One-way ANOVA across all ages, p=0.0544, 976	
n=1 specimen per gestational age. All error bars represent  ± SEM.  977	
 978	
Figure 2: Juxtavascular microglia predominantly contact capillaries in the postnatal 979	
cortex. A. A representative image of a juxtavascular microglia (filled arrowhead) in the P5 980	
frontal cortex. Microglia are labeled using the Cx3cr1EGFP/+ reporter mouse (green; Ai) and 981	
immunolabeling for a microglia-specific marker anti-P2RY12 (red; Aii.). The vasculature is 982	
labeled with anti-PECAM (magenta) in the merged image (Aiii.). Scale bar= 10µm. B. A 983	
representative image of LYVE1-negative microglia (green, EGFP, filled arrowheads) and 984	
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LYVE1-positive perivascular macrophages (gray, anti-LYVE1, unfilled arrowheads) associated 985	
with vasculature (magenta, anti-PECAM) in the P5 frontal cortex. Scale bar= 10µm. C. 986	
Quantification of juxtavascular microglia across development labeled either with EGFP in 987	
Cx3cr1 EGFP/+ mice (black bars) or anti-P2RY12 in wild type mice (WT, white bars) frontal 988	
cortices. Two-way ANOVA with a Sidak’s post hoc; n=3-4 littermates per genotype per 989	
developmental time point. D. Quantification of vascular density in Cx3cr1 EGFP/+ (black bars) and 990	
WT (white bars) frontal cortices over development. Two-way ANOVA with a Sidak’s post hoc; 991	
n=3-4 littermates per genotype per developmental time point. E. Quantification of the percent of 992	
juxtavascular microglia contacting branched (black bars) or unsegmented (gray bars) vessels.  993	
Two-way ANOVA with a Sidak’s post hoc; n=3-4 littermates per developmental time point, 994	
*p<.05, ***p<.001, ****p<.0001.  F. A representative image of a juxtavascular microglia (green, 995	
EGFP, filled arrowhead) contacting smooth muscle cell actin (gray, SMA)-negative capillaries 996	
(magenta; PDGFRβ) in the P5 frontal cortex. Scale bar= 10µm G. Quantification of the percent 997	
of juxtavascular microglia contacting SMA-positive or -negative vessels at P5 and P≥21 in the 998	
frontal cortex. Two-way ANOVA with a Sidak’s post hoc; n=3 littermates per genotype per 999	
developmental time point, ****p<.0001. H. Quantification of the percent of juxtavascular 1000	
microglia contacting vessels ≤8µm and >8µm at P5 and P≥21 in the frontal cortex. Two-way 1001	
ANOVA with a Sidak’s post hoc; n=4 littermates per genotype per developmental time point, 1002	
****p<.0001. All error bars represent ± SEM.    1003	
    1004	
Figure 3: Microglia associate and align with vasculature as they colonize the cortex in a 1005	
rostral-to-caudal gradient. A. Tiled sagittal sections of a P1 (Ai), P7 (Aii), and P14 (Aiii.) 1006	
Cx3cr1EGFP/+ brain. The dotted yellow and red lines outline the frontal and somatosensory cortex, 1007	
respectively. Scale bars= 400µm. B-C. Left Y axis and gray bars: quantification of microglial 1008	
density over development in the frontal cortex (B) and somatosensory cortex (C). One-way 1009	
ANOVA with Dunnett’s post hoc; comparison to P≥21, n=4 littermates per developmental time 1010	
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point, *p<.05, **p<.01, ****p<.0001. Right Y axis and black line graphs: the percent of the total 1011	
microglia population associated with vasculature over development in the frontal cortex (B) and 1012	
somatosensory cortex (C). Note, data corresponding to the percent of juxtavascular microglia in 1013	
the frontal cortex (line graph in C) are the same as presented in Fig. 1G. One-way ANOVA with 1014	
Dunnett’s post hoc; comparison to P≥21, n=4 littermates per developmental time point, 1015	
++++p<.0001. D-E. Representative images of juxtavascular microglia (EGFP, green in Di and 1016	
Ei; black in Dii and Eii) primary processes aligned parallel (D) with vessels (magenta, anti-1017	
PECAM) in the P5 frontal cortex, which were largely not aligned at P28 (E). Filled arrowheads 1018	
denote processes aligned parallel to the vessel and unfilled arrowheads denote those microglial 1019	
processes that are not aligned with the vessel. The dotted magenta line in Dii and Eii outline the 1020	
vessel in Di and Ei.  Scale bars= 10µm. F-G. Quantification of the percent of juxtavascular 1021	
primary processes that are aligned parallel with vessels in the frontal (F) and somatosensory 1022	
(G) cortices over development. One-way ANOVA with Dunnett’s post hoc; comparison to P≥21, 1023	
n=3-4 littermates per developmental time point, *** p<.001, ****p<.0001. All error bars represent 1024	
± SEM.    1025	
 1026	
Figure 4: A high percentage of microglia associate with vasculature as they are recruited 1027	
to synapses in the cortex in a CX3CR1-dependent manner. Ai-Aii. Layer IV of the barrel 1028	
cortex contains thalamocortical synapses, which form a highly precise synaptic map of the 1029	
vibrissae (whiskers) on the snout. Aiii. A low magnification representative image of a tangential 1030	
section through layer IV of the barrel cortex shows layer IV thalamocortical presynaptic 1031	
terminals (red, anti-VGluT2), form discrete barrel structures corresponding to each whisker, 1032	
which are separated by septa where thalamocortical terminals are largely absent. Microglia are 1033	
labeled by EGFP (green) and the vasculature is labeled with anti-PECAM (gray). White box 1034	
denotes a single barrel. Scale bar= 100µm. B. Quantification of the number of microglia per 1035	
mm2 within the barrel centers in developing Cx3cr1+/- (black bars) and Cx3cr1-/- (gray bars) 1036	
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mice. Two-way ANOVA with a Sidak’s post hoc; n=4 littermates per genotype per 1037	
developmental time point; ** p<.01, ***p<.001. C-D. Representative images of quantification in 1038	
B. Images are zoomed in to show single barrels within tangential sections of layer IV of the 1039	
barrel cortex (denoted by white box in Aiii) where microglia (green) are recruited to barrel 1040	
centers in Cx3cr1+/- by P7 (C) and in Cx3cr1-/- by P8 (D). Asterisks denote microglia located 1041	
within barrel centers. The dotted yellow lines denote the perimeters of the VGluT2-positive 1042	
thalamocortical inputs (red), which define the barrels vs. the septa. Scale bars= 30µm. E-F. The 1043	
same representative fields of view in C-D but lacking the anti-VGluT2 channel and, instead, 1044	
including the channel with anti-PECAM immunostaining (magenta) to label the vessels. 1045	
Microglia are still labeled with EGFP (green). Dotted yellow lines still denote the perimeters of 1046	
the VGluT2-posiive barrels (red in C-D). Juxtavascular microglia in Cx3cr1+/- and Cx3cr1-/- mice 1047	
are denoted by filled arrowheads. Scale bar= 30µm. G. Quantification of the percent of microglia 1048	
associated with the vasculature in Cx3cr1+/- (black lines) and Cx3cr1-/– (gray lines) animals over 1049	
development in layer IV of the barrel cortex demonstrates a peak of vascular association in 1050	
Cx3cr1+/- mice at P5-P6, which is delayed to P7-P8 in Cx3cr1-/- coincident with delayed 1051	
microglial recruitment to barrel centers. Two-way ANOVA with a Tukey’s post hoc; n=4-5 1052	
littermates per genotype per developmental time point; *p<.05, ***p<.001, compared to P9 1053	
Cx3cr1+/-. H-I. Quantification of microglial (H) and vascular (I) density in Cx3cr1+/- (black bars) 1054	
and Cx3cr1-/- (gray bars) animals over development in layer IV of the barrel cortex. Two-way 1055	
ANOVA with a Sidak’s post hoc; n=4 littermates per genotype per developmental time point. All 1056	
error bars represent ± SEM. 1057	
 1058	
Figure 5: Juxtavascular microglia migrate along blood vessels as they colonize the 1059	
developing brain and are largely stationary in adulthood. A. A schematic of the live imaging 1060	
experiment. Cx3cr1EGFP/+ mice received a retro-orbital injection of Texas red labeled dextran to 1061	
label the vasculature 10 minutes prior to euthanasia. Coronal somatosensory cortices were cut 1062	
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and imaged every 5 minutes over 6 hours immediately following slice preparation. B-C. 1063	
Representative fluorescent images from a 6-hour live imaging session from a P7 (B) and P≥120 1064	
(C) slice. Filled arrowheads indicate microglial soma position at t=0. Unfilled arrowheads 1065	
indicate the location of the same microglial soma at 0hr (Bi, Ci), 1hrs (Bii, Cii), 2hrs (Biii, Ciii), 1066	
3hrs (Biv, Civ), 4hrs (Bv, Cv), 5hrs (Bvi, Cvi), and 6hrs (Bvii, Cvii).  See also Movies 3-6. 1067	
Scale bars= 30µm. D. Quantification of juxtavascular (black bars) and vascular-unassociated 1068	
(gray bars) microglia soma motility speed/velocity. Two-way ANOVA with a Sidak’s post hoc; 1069	
n=4 mice per time point; **p<.01, ***p<.001. E. Quantification of the distance traveled of 1070	
juxtavascular (black bars) and vascular-unassociated (gray bars) microglia somas in the P7 1071	
somatosensory cortex. Two-way ANOVA with a Sidak’s post hoc; n=4 mice; **p<.01, ***p<.001, 1072	
****p<.0001. F. Quantification of migratory juxtavascular microglia trajectory angles in the P7 1073	
somatosensory cortex. Unpaired student’s t-test; n=4 mice per time point; ****p<.0001. G. A 1074	
schematic of short-term 2-photon live imaging experiment in adult cortex. Cx3cr1EGFP/+ mice 1075	
received a retro-orbital injection of Texas Red-labeled dextran to visualize the vasculature 10 1076	
min prior to each imaging session. EGFP+ juxtavascular microglia were then imaged every 5 1077	
minutes for 2 hours. See also Movie 7. H. Quantification of the percent of juxtavascular (black 1078	
bars) and vascular-unassociated (gray bars) microglia that remain stationary for 2 hours. 1079	
Unpaired student’s t-test; n=3 mice per developmental time point. I. A schematic of the long-1080	
term 2-photon live imaging experiment in adult visual cortex. Cx3cr1EGFP/+ mice received a retro-1081	
orbital injection of Texas Red-labeled dextran to visualize the vasculature 10 min prior to each 1082	
imaging session. EGFP+ juxtavascular microglia were then imaged for 6 weeks. J. 1083	
Quantification of the percent of juxtavascular microglia on vessels on day 0 that remain on 1084	
vessels through six weeks of imaging. Data are representative of n=3 mice. K. Representative 1085	
fluorescent images acquired during a 6-week live imaging session from a single mouse. Filled 1086	
arrowheads indicate juxtavascular microglia that remain on vessels for 6 weeks. Unfilled 1087	
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arrowhead indicates a juxtavascular microglia that changes position, but remains on the 1088	
vasculature, over 6 weeks. All error bars represent ± SEM.  1089	
 1090	
Figure 6: Juxtavascular microglia contact the cortical vasculature in areas lacking full 1091	
astrocytic endfoot coverage. A-C. Representative single optical plane images and 3D 1092	
rendering (Aiv-Civ; see also Movies 8-10) of juxtavascular microglia (green, EGFP) and blood 1093	
vessels (magenta, anti-PDGFRβ) in areas void of astrocytic endfoot labeling (gray, anti-AQP4) 1094	
in the frontal cortex at P5 (A), P7 (B) P28 (C). Filled arrowheads denote vascular areas that lack 1095	
astrocyte endfeet where juxtavascular microglia are contacting the vessel. Scale bars= 10µm. 1096	
D. Left Y axis, gray bars: quantification of the percent of blood vessels covered by astrocyte 1097	
endfeet over development in the frontal cortex. One-way ANOVA with Dunnett’s post hoc; 1098	
comparison to P≥21, n=3 littermates per developmental time point, ***p<.001, ****p<.0001. 1099	
Right Y axis, black line: the percent of the total microglia population that are juxtavascular over 1100	
development in the frontal cortex (data are the same as presented in Fig. 1G). One-way ANOVA 1101	
with Dunnett’s post hoc; comparison to P≥21, n=4 littermates per developmental time point, 1102	
++++p<.0001. E. Quantification of the percent of juxtavascular microglia contacting vessels 1103	
only, vessels and astrocyte endfeet (representative images in A-C), and astrocyte endfeet only 1104	
from 3D rendered images. F-I. Representative expansion microscopy (ExM, F-G) and structured 1105	
illumination microscopy (SIM, H-I) images of juxtavascular microglia (green, EGFP), in vascular 1106	
areas lacking anti-AQP4 (gray) astrocytic endfoot labeling (filled arrowheads) in the P5 (F, H) 1107	
and P28 (G, I) frontal cortex. Scale bars= 10µm.  All error bars represent ± SEM.   1108	
 1109	
Figure 7: Ultrastructural analysis by EM reveals that juxtavascular microglia directly 1110	
contact the basal lamina of the vasculature 1111	
A-B. Electron microscopy (EM) of juxtavascular microglia (green pseudocoloring) contacting the 1112	
basal lamina (purple line) of a blood vessel in an area void of astrocyte endfeet (blue 1113	
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pseudocoloring) in the P5 ( A, left column) and P56 (B, right column) frontal cortex. Pink 1114	
pseudocoloring denotes a pericyte. Asterisks denote microglia nuclei. Scale bar= 5µm. The 1115	
black box denotes the magnified inset in the bottom right corner where microglia (green 1116	
pseudocoloring) directly contact the basal lamina (unlabeled in the inset) and only partially 1117	
contacts the astrocyte endfoot (blue pseudocoloring). Scale bar= 1µm. C. 3D reconstruction of 1118	
serial EM of P5 juxtavascular microglia in Aiii (Ci) and P56 P56 juxtavascular microglia in Biii 1119	
(Cii) (see also Movies 11 and 12).  1120	
 1121	
Movie 1: 3D rendering of juxtavascular microglia in the early postnatal frontal cortex. 3D 1122	
reconstruction and surface rendering of juxtavascular microglia (green, EGFP) associated with 1123	
blood vessels (magenta, anti-PECAM) in the P5 frontal cortex. Yellow denotes contact area 1124	
between microglia and blood vessels. 1125	
 1126	
Movie 2: 3D rendering of juxtavascular microglia in the P28 frontal cortex. 3D 1127	
reconstruction and surface rendering of juxtavascular microglia (green, EGFP) associated with 1128	
blood vessels (magenta, anti-PECAM) in the P28 frontal cortex. Yellow denotes contact area 1129	
between microglia and blood vessels. 1130	
 1131	
Movie 3: Juxtavascular microglial migration in the early postnatal somatosensory cortex. 1132	
Representative live imaging of juxtavascular microglia (green, EGFP) migrating on vessels 1133	
(magenta; dextran) in the P7 somatosensory. Cx3cr1EGFP/+ mice received a retro-orbital injection 1134	
of Texas red labeled dextran to label the vasculature 10 minutes prior to euthanasia. Coronal 1135	
somatosensory cortices were imaged every 5 minutes over 6 hours immediately following slice 1136	
preparation. Asterisk in still image denotes the microglia that was tracked for quantification. 1137	
 1138	
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Movie 4: Juxtavascular microglial migration in the early postnatal somatosensory cortex.  1139	
A second representative live imaging of juxtavascular microglia (green, EGFP) migrating on 1140	
vessels (magenta; dextran) in the P7 somatosensory. Cx3cr1EGFP/+ mice received a retro-orbital 1141	
injection of Texas red labeled dextran to label the vasculature 10 minutes prior to euthanasia. 1142	
Coronal somatosensory cortices were imaged every 5 minutes over 6 hours immediately 1143	
following slice preparation. Asterisk in still image denotes the microglia that was tracked for 1144	
quantification. 1145	
 1146	
Movie 5: Juxtavascular microglial migration in the early postnatal somatosensory cortex. 1147	
A third representative live imaging of juxtavascular microglia (green, EGFP) migrating on 1148	
vessels (magenta; dextran) in the P7 somatosensory. Cx3cr1EGFP/+ mice received a retro-orbital 1149	
injection of Texas red labeled dextran to label the vasculature 10 minutes prior to euthanasia. 1150	
Coronal somatosensory cortices were imaged every 5 minutes over 6 hours immediately 1151	
following slice preparation. Asterisk in still image denotes the microglia that was tracked for 1152	
quantification. 1153	
. 1154	
Movie 6: Juxtavascular microglial migration in the adult somatosensory cortex. 1155	
Representative live imaging of juxtavascular microglia (green, EGFP) stationary on vessels 1156	
(magenta; dextran) in the P≥120 somatosensory cortex. Cx3cr1EGFP/+ mice received a retro-1157	
orbital injection of Texas red labeled dextran to label the vasculature 10 minutes prior to 1158	
euthanasia. Coronal somatosensory cortices were imaged every 5 minutes over 6 hours 1159	
immediately following slice preparation. Asterisk in still image denotes the microglia that was 1160	
tracked for quantification. 1161	
 1162	
 1163	
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Movie 7: 2-photon in vivo live imaging of juxtavascular microglia in the adult cortex. 1164	
Representative 2-photon in vivo live imaging of juxtavascular microglia (green, EGFP) stationary 1165	
on blood vessels (magenta, dextran) over 2 hours in vivo in the adult cortex. Cx3cr1EGFP/+ mice 1166	
received a retro-orbital injection of Texas Red-labeled dextran to visualize the vasculature 10 1167	
min prior to each imaging session. EGFP+ juxtavascular microglia were then imaged every 5 1168	
minutes for 2 hours. 1169	
 1170	
Movie 8: Juxtavascular microglia contact the cortical vasculature in areas lacking full 1171	
astrocytic endfoot coverage in the P5 frontal cortex. 3D reconstruction and surface 1172	
rendering of juxtavascular microglia (green, EGFP) contacting blood vessels (magenta, anti-1173	
PDGFRβ) in areas void of astrocytic endfoot labeling (gray, anti-AQP4) in the frontal cortex at 1174	
P5. 1175	
 1176	
Movie 9: Juxtavascular microglia contact the cortical vasculature in areas lacking full 1177	
astrocytic endfoot coverage in the P7 frontal cortex. 3D reconstruction and surface 1178	
rendering of juxtavascular microglia (green, EGFP) contacting blood vessels (magenta, anti-1179	
PDGFRβ) in areas void of astrocytic endfoot labeling (gray, anti-AQP4) in the frontal cortex at 1180	
P7. 1181	
 1182	
Movie 10: Juxtavascular microglia contact the cortical vasculature in areas lacking full 1183	
astrocytic endfoot coverage in the P28 frontal cortex. 3D reconstruction and surface 1184	
rendering of juxtavascular microglia (green, EGFP) contacting blood vessels (magenta, anti-1185	
PDGFRβ) in areas void of astrocytic endfoot labeling (gray, anti-AQP4) in the frontal cortex at 1186	
P28. 1187	
 1188	
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Movie 11: Serial EM 3D reconstruction of juxtavascular microglia in the early postnatal 1189	
cortex. 3D reconstruction of serial electron microscopy (EM) of juxtavascular microglia (green) 1190	
contacting the basal lamina (red) of a blood vessel in an area void of astrocyte endfeet (blue) in 1191	
the P5 frontal cortex.  1192	
 1193	
Movie 12: Serial EM 3D reconstruction of juxtavascular microglia in the P56 cortex. 3D 1194	
reconstruction of serial electron microscopy (EM) of juxtavascular microglia (green) contacting 1195	
the basal lamina (red) of a blood vessel lacking full astrocyte endfoot (blue) coverage in the P56 1196	
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